دواعي استعمال اولتيبرو بريزهيلر 110/50مكجم 30 جرعة كبسولات + جهاز استنشاق
معلومات من نشرات دوائية ومراجع موثقة، مع مصدر كل معلومة. السعر الحالي: 550.25ج.م.
دواعي الاستعمال
- Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).الفئة: AdultsEuropean Medicines Agency (EMA)
الآثار الجانبية
- Most common adverse reactions: cough, nasopharyngitis and headache; typical anticholinergic and beta-adrenergic effects of the components.نشرة دولية لنفس المنتج · European Medicines Agency (EMA)
موانع الاستعمال
- Hypersensitivity to the active substances or to any of the excipients (capsules contain lactose monohydrate).نشرة دولية لنفس المنتج · European Medicines Agency (EMA)
تحذيرات واحتياطات
- Not for treatment of asthma and not for acute episodes of bronchospasm; do not combine with other LABA or LAMA medicines.نشرة دولية لنفس المنتج · European Medicines Agency (EMA)
- Paradoxical bronchospasm (potentially life-threatening) and immediate hypersensitivity reactions: discontinue immediately.نشرة دولية لنفس المنتج · European Medicines Agency (EMA)
- Use with caution in narrow-angle glaucoma, urinary retention, cardiovascular disorders, convulsive disorders, thyrotoxicosis and diabetes (hypokalaemia and hyperglycaemia possible).نشرة دولية لنفس المنتج · European Medicines Agency (EMA)
التداخلات الدوائية
- Beta-adrenergic blockers (including eye drops)May weaken or antagonise the effect of beta2-agonists; avoid unless compelling reasons (prefer cardioselective, with caution).European Medicines Agency (EMA)
- Other anticholinergic medicinesCo-administration not studied and not recommended.European Medicines Agency (EMA)
- Methylxanthines, steroids, non-potassium-sparing diureticsMay potentiate hypokalaemic effect; use with caution.European Medicines Agency (EMA)
الحمل والرضاعة
- No data in pregnant women; indacaterol may inhibit labour. Use in pregnancy only if expected benefit justifies the potential risk to the foetus.نشرة دولية لنفس المنتج · European Medicines Agency (EMA)
- Unknown whether excreted in human milk (excreted in rat milk); consider only if expected benefit to the woman outweighs any possible risk to the infant.نشرة دولية لنفس المنتج · European Medicines Agency (EMA)
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- European Medicines Agency (EMA)
- PubChem (NCBI)
- PubChem (NCBI)